Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Company Profile for Genomatix Corporation.


Genomatix specializes in the modular production of custom multigenic targeting vectors Vectors
Something used to transport genetic information to a cell.

Mentioned in: Gene Therapy
 that can deliver one or more gene programs to specific loci loci

[L.] plural of locus.

loci Plural of locus, see there
 in host genomes. Multigenic targeting solutions play an increasingly important role in genetics-based therapeutic research, where the need for locus-specific, single-copy insertion insertion n. the addition of language at a place within an existing typed or written document, which is always suspect unless initialled by all parties.  of integrated gene programs is an essential aspect of ensuring accurate research data, precise genetic control and subsequent therapeutic efficacy efficacy /ef·fi·ca·cy/ (ef´i-kah-se)
1. the ability of an intervention to produce the desired beneficial effect in expert hands and under ideal circumstances.

2.
 and safety.
Company:                Genomatix Corporation

   Headquarters Address:   119 Norfolk Avenue, SW
                           Laboratory Suite 100
                           Roanoke, Virginia 24011

   Main Telephone:         540-345-4333

   Type of Organization:   Private

   Industry:               Biotechnology

   Key Executives:         Chairman: Thomas Reed
                           CEO: Robert Beech

   Public Relations
     Contact:              Robert Beech
     Phone:                540-345-4333
     Email:                rbeech@genomatix.com

   Investor Relations
     Contact:              Robert Beech
     Phone:                540-345-4333
     Email:                rbeech@genomatix.com

   Customer Service
     Contact:              Scott Patterson
     Phone:                513-345-4333
     Email:                spatterson@genomatix.com
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 15, 2004
Words:131
Previous Article:Initial Determination of the U.S. International Trade Commission Upholds the Validity of American Biophysics Corporation's Pioneering Patent.
Next Article:Robert Mondavi Corporation Announces Strategy to Focus on Lifestyle Wine Segment; Company Explores Divestiture of its Luxury Assets; Fiscal 2005...



Related Articles
DoubleTwist Announces New Customers, Realigned Management Team.
Genomatix Corporation Relocates to Southwestern Virginia; Genomatix Corporation, a Genetic Materials Manufacturer, Has Relocated Its Operations to...
Company Profile for Genomatix Corporation.
Lynx Announces Publication of a Scientific Paper Showcasing the Usefulness of MPSS for Whole Genome Structure Analysis.
Genomatix Offers Multigenic SNP Knockin Vectors.
Kinase Knockdown Vectors Now Include Multigenics.
Genomatix Now Offers mDECOY Kinase Kits.
Genomatix Corporation Closes Series B Financing Round.
Biotech Company Changes Name to Intrexon Corporation; Genomatix Corporation Today Announced That It Has Changed Its Corporate Name to Intrexon...
Insight into Bioinformatics Technology Can Be Sought inside the 2006 Global Strategic Business Report on Bioinformatics.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles